Analyst Research

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Concord Medical Services Holdings Ltd Reiterates FY 2013 Revenue Guidance; Updates FY 2013 EBITDA Guidance


Tuesday, 12 Nov 2013 06:01pm EST 

Concord Medical Services Holdings Ltd announced that based on current market and operating conditions, estimated business expansion and forecasted Chang'an Hospital financial results, Concord Medical reiterates its fiscal 2013 guidance forecast of total estimated net revenue in the range of RMB930 million to RMB975 million. Fiscal 2013 adjusted EBITDA is expected to grow from 10% to 15% compared to fiscal 2012. 

Company Quote

7.39
0.26 +3.65%
17 Apr 2014